This grant, from the National Heart, Lung, and Blood Institute (NHLBI), supports Phase 3 of the Molecular Atlas of Lung Development Program (LungMAP). The primary aim is to construct a detailed molecular and cellular atlas of the human lung. This atlas will serve as a vital reference to deepen understanding of normal lung biology and disease mechanisms, helping identify critical cellular components, molecular pathways, and new therapeutic targets for lung diseases. Awarded Research Centers (RCs) will collect and analyze pediatric and adult diseased lung tissues, generating high-resolution molecular profiling data. RCs are expected to perform integrated data analysis, investigate disease pathogenesis, collaborate with other LungMAP teams, and disseminate this valuable resource to the wider scientific community. Previous LungMAP Phase 2 funding is not a prerequisite for application.
Opportunity ID: 349292
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-HL-24-006 |
| Funding Opportunity Title: | Molecular Atlas of Lung Development Program (LungMAP) Phase 3 – Research Centers (U01 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.838 — Lung Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jul 14, 2023 |
| Last Updated Date: | Jul 14, 2023 |
| Original Closing Date for Applications: | Oct 27, 2023 |
| Current Closing Date for Applications: | Oct 27, 2023 |
| Archive Date: | Dec 02, 2023 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | County governments State governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education Private institutions of higher education City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Special district governments Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Independent school districts |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this NOFO is to support the Molecular Atlas of Lung Development Program (LungMAP) Phase 3 Research Centers (RCs). The overall goal of LungMAP is to build a comprehensive molecular and cellular atlas of the human lung to serve as a reference platform to better understand both normal biology and disease pathobiology, and to identify critical cellular components, molecular pathways, and novel therapeutic targets in lung disease. RCs will be expected to obtain and analyze pediatric and adult lung tissues in order to generate high-resolution molecular profiling data of the diseased lung. RCs will perform integrated data analysis, explore mechanisms of disease pathogenesis, collaborate closely with other LungMAP teams and to disseminate this resource to the broader research community. Applicants are not required to have been funded in LungMAP Phase 2 (RFA-HL-19-020) in order to submit applications to this NOFO. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-24-006.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 349292 Full Announcement-RFA-HL-24-006 -> RFA-HL-24-006-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00282564 | Sep 27, 2023 | Oct 27, 2023 | View |
Package 1
Mandatory forms
349292 RR_SF424_5_0-5.0.pdf
349292 PHS398_CoverPageSupplement_5_0-5.0.pdf
349292 RR_OtherProjectInfo_1_4-1.4.pdf
349292 PerformanceSite_4_0-4.0.pdf
349292 RR_KeyPersonExpanded_4_0-4.0.pdf
349292 PHS398_ResearchPlan_5_0-5.0.pdf
349292 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
349292 RR_Budget_3_0-3.0.pdf
349292 RR_SubawardBudget30_3_0-3.0.pdf
349292 PHS398_ModularBudget_1_2-1.2.pdf
349292 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
